20 million euro EIB support for innovative medical technologyMarch 23, 2018
Hat: 20 million euro EIB support for innovative medical technology
Funding Scheme: 2018-03-23
Pgm2014 2020: Yes
The European Investment Bank has allocated 20 million euro through the European Strategic Investment Fund to MedinCell to develop new injectable controlled and prolonged treatment therapies to significantly improve the management and delivery of medicines and quality of life of patients.
This is the 120th operation approved in France as part of the Investment Plan for Europe, more commonly called Plan Juncker, one of whose key objectives is to support the development of innovative companies in Europe.
MedinCell is an innovative company specializing in injectable medical treatments with controlled and prolonged action.
This EU loan will serve to develop innovative treatments to replace daily drug administration with a simple subcutaneous or local injection, thereby substantially enhancing patient care and quality of life.
Url description: European Investment Bank